The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Latest Articles

Published online
doi:10.1084/jem.20080129
The Journal of Experimental Medicine
The Rockefeller University Press, 0022-1007 $30.00
© Albanesi et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 6165K)
Right arrow PDF+supp data (10519K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Albanesi, C.
Right arrow Articles by Sozzani, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Albanesi, C.
Right arrow Articles by Sozzani, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment

Cristina Albanesi1, Claudia Scarponi1, Sabatino Pallotta1, Roberta Daniele2,3, Daniela Bosisio2, Stefania Madonna1, Paola Fortugno1, Safiyè Gonzalvo-Feo4, Jean-Denis Franssen5, Marc Parmentier6, Ornella De Pità1, Giampiero Girolomoni3, and Silvano Sozzani2

1 Istituto Dermopatico dell'Immacolata, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00167 Rome, Italy
2 Department of Biomedical Sciences and Biotechnology, Section of General Pathology and Immunology, University of Brescia, 25123 Brescia, Italy
3 Department of Biomedical and Surgical Sciences, Section of Dermatology and Venereology, University of Verona, 37126 Verona, Italy
4 IRCCS Istituto Clinico Humanitas, 20089 Rozzano, Italy
5 Euroscreen s.a., 6041Gosselies, Belgium
6 Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Campus Erasme, 1070 Brussels, Belgium

CORRESPONDENCE Silvano Sozzani: sozzani{at}med.unibs.it

Psoriasis is a type I interferon-driven T cell–mediated disease characterized by the recruitment of plasmacytoid dendritic cells (pDC) into the skin. The molecules involved in pDC accumulation in psoriasis lesions are unknown. Chemerin is the only inflammatory chemotactic factor that is directly active on human blood pDC in vitro. The aim of this study was to evaluate the role of the chemerin/ChemR23 axis in the recruitment of pDC in psoriasis skin. Prepsoriatic skin adjacent to active lesions and early lesions were characterized by a strong expression of chemerin in the dermis and by the presence of CD15+ neutrophils and CD123+/BDCA-2+/ChemR23+ pDC. Conversely, skin from chronic plaques showed low chemerin expression, segregation of neutrophils to epidermal microabscesses, and few pDC in the dermis. Chemerin expression was localized mainly in fibroblasts, mast cells, and endothelial cells. Fibroblasts cultured from skin of psoriatic lesions expressed higher levels of chemerin messenger RNA and protein than fibroblasts from uninvolved psoriatic skin or healthy donors and promoted pDC migration in vitro in a chemerin-dependent manner. Therefore, chemerin expression specifically marks the early phases of evolving skin psoriatic lesions and is temporally strictly associated with pDC. These results support a role for the chemerin/ChemR23 axis in the early phases of psoriasis development.


Abbreviations used: AD, atopic dermatitis; LS, lesional; mRNA, messenger RNA; NLS, nonlesional; pDC, plasmacytoid DC.

G. Girolomoni and S. Sozzani contributed equally to this paper.

© 2009 Albanesi et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search